Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-19

Clinical Trial Update: Interferon-Alpha for Diabetes Mellitus Type 1 [Phase 2]

View source ↗

Summary

Phase 2 study of interferon-alpha in type 1 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon-alpha (interferon alpha)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Insulin-Dependent Diabetes Mellitus | Phase 2 | Status: COMPLETED